These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 32325827)

  • 1. Tumor-Targeted Delivery of the p53-Activating Peptide VIP116 with PEG-Stabilized Lipodisks.
    Lundsten S; Hernández VA; Gedda L; Sarén T; Brown CJ; Lane DP; Edwards K; Nestor M
    Nanomaterials (Basel); 2020 Apr; 10(4):. PubMed ID: 32325827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stapled peptides as scaffolds for developing radiotracers for intracellular targets: Preliminary evaluation of a radioiodinated MDM2-binding stapled peptide in the SJSA-1 osteosarcoma model.
    Zhou Z; Zalutsky MR; Chitneni SK
    Bioorg Med Chem Lett; 2022 Jun; 66():128725. PubMed ID: 35436588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting lipodisks enable selective delivery of anticancer peptides to tumor cells.
    Ahlgren S; Reijmar K; Edwards K
    Nanomedicine; 2017 Oct; 13(7):2325-2328. PubMed ID: 28712916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of lipodisk properties by modification of the extent and density of the PEG corona.
    Zetterberg MM; Ahlgren S; Agmo Hernández V; Parveen N; Edwards K
    J Colloid Interface Sci; 2016 Dec; 484():86-96. PubMed ID: 27592189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ratiometric co-encapsulation and co-delivery of doxorubicin and paclitaxel by tumor-targeted lipodisks for combination therapy of breast cancer.
    Feng C; Zhang H; Chen J; Wang S; Xin Y; Qu Y; Zhang Q; Ji W; Yamashita F; Rui M; Xu X
    Int J Pharm; 2019 Apr; 560():191-204. PubMed ID: 30769131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterizing and Controlling the Loading and Release of Cationic Amphiphilic Peptides onto and from PEG-Stabilized Lipodisks.
    Reijmar K; Edwards K; Andersson K; Agmo Hernández V
    Langmuir; 2016 Nov; 32(46):12091-12099. PubMed ID: 27788004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immobilized lipodisks as model membranes in high-throughput HPLC-MS analysis.
    Meiby E; Zetterberg MM; Ohlson S; Hernández VA; Edwards K
    Anal Bioanal Chem; 2013 May; 405(14):4859-69. PubMed ID: 23512190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Label-free characterization of peptide-lipid interactions using immobilized lipodisks.
    Agmo Hernández V; Reijmar K; Edwards K
    Anal Chem; 2013 Aug; 85(15):7377-84. PubMed ID: 23829826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53-Mediated Radiosensitization of
    Lundsten S; Berglund H; Jha P; Krona C; Hariri M; Nelander S; Lane DP; Nestor M
    Biomolecules; 2021 Nov; 11(11):. PubMed ID: 34827693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the MDM2/MDM4 interaction interface as a promising approach for p53 reactivation therapy.
    Pellegrino M; Mancini F; Lucà R; Coletti A; Giacchè N; Manni I; Arisi I; Florenzano F; Teveroni E; Buttarelli M; Fici L; Brandi R; Bruno T; Fanciulli M; D'Onofrio M; Piaggio G; Pellicciari R; Pontecorvi A; Marine JC; Macchiarulo A; Moretti F
    Cancer Res; 2015 Nov; 75(21):4560-72. PubMed ID: 26359458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The fluorescent two-hybrid assay to screen for protein-protein interaction inhibitors in live cells: targeting the interaction of p53 with Mdm2 and Mdm4.
    Yurlova L; Derks M; Buchfellner A; Hickson I; Janssen M; Morrison D; Stansfield I; Brown CJ; Ghadessy FJ; Lane DP; Rothbauer U; Zolghadr K; Krausz E
    J Biomol Screen; 2014 Apr; 19(4):516-25. PubMed ID: 24476585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the Efficacy of Mdm2/Mdm4-Inhibiting Stapled Peptides Using Cellular Thermal Shift Assays.
    Tan BX; Brown CJ; Ferrer FJ; Yuen TY; Quah ST; Chan BH; Jansson AE; Teo HL; Nordlund P; Lane DP
    Sci Rep; 2015 Jul; 5():12116. PubMed ID: 26159518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HDL-mimicking peptide-lipid nanoparticles with improved tumor targeting.
    Zhang Z; Chen J; Ding L; Jin H; Lovell JF; Corbin IR; Cao W; Lo PC; Yang M; Tsao MS; Luo Q; Zheng G
    Small; 2010 Feb; 6(3):430-7. PubMed ID: 19957284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lanthanide-doped nanoparticles conjugated with an anti-CD33 antibody and a p53-activating peptide for acute myeloid leukemia therapy.
    Niu F; Yan J; Ma B; Li S; Shao Y; He P; Zhang W; He W; Ma PX; Lu W
    Biomaterials; 2018 Jun; 167():132-142. PubMed ID: 29571049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanistic validation of a clinical lead stapled peptide that reactivates p53 by dual HDM2 and HDMX targeting.
    Wachter F; Morgan AM; Godes M; Mourtada R; Bird GH; Walensky LD
    Oncogene; 2017 Apr; 36(15):2184-2190. PubMed ID: 27721413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptides and peptidomimetics in the p53/MDM2/MDM4 circuitry - a patent review.
    Teveroni E; Lucà R; Pellegrino M; Ciolli G; Pontecorvi A; Moretti F
    Expert Opin Ther Pat; 2016 Dec; 26(12):1417-1429. PubMed ID: 27603098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A stapled peptide antagonist of MDM2 carried by polymeric micelles sensitizes glioblastoma to temozolomide treatment through p53 activation.
    Chen X; Tai L; Gao J; Qian J; Zhang M; Li B; Xie C; Lu L; Lu W; Lu W
    J Control Release; 2015 Nov; 218():29-35. PubMed ID: 26428461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cetuximab-oxaliplatin-liposomes for epidermal growth factor receptor targeted chemotherapy of colorectal cancer.
    Zalba S; Contreras AM; Haeri A; Ten Hagen TL; Navarro I; Koning G; Garrido MJ
    J Control Release; 2015 Jul; 210():26-38. PubMed ID: 25998052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancing Specific Disruption of Intracellular Protein Complexes by Hydrocarbon Stapled Peptides Using Lipid Based Delivery.
    Thean D; Ebo JS; Luxton T; Lee XC; Yuen TY; Ferrer FJ; Johannes CW; Lane DP; Brown CJ
    Sci Rep; 2017 May; 7(1):1763. PubMed ID: 28496125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted delivery of a novel palmitylated D-peptide for antiglioblastoma molecular therapy.
    Li C; Shen J; Wei X; Xie C; Lu W
    J Drug Target; 2012 Apr; 20(3):264-71. PubMed ID: 22233211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.